Phospho-PTK2B (Y579) Antibody

What is the significance of PTK2B Y579 phosphorylation in cellular signaling?

PTK2B Y579 phosphorylation represents a critical step in the activation sequence of this kinase. While Tyr-402 serves as the major autophosphorylation site, phosphorylation at Tyr-579 occurs downstream of this initial event and is primarily mediated by Src family kinases. The phosphorylation cascade typically begins with PTK2B autophosphorylation at Y402, which creates a binding site for Src and Src family members. This interaction subsequently leads to phosphorylation at Tyr-579, Tyr-580, and Tyr-881, with Y579/Y580 phosphorylation being crucial for full kinase activation . This phosphorylation sequence is essential for creating additional binding sites for scaffold proteins, effectors, and substrates, enabling the formation of multisubunit signaling complexes that regulate numerous pathways including MAP kinase, phosphatidylinositol 3-kinase, and Rho family GTPases .

What are the recommended applications for Phospho-PTK2B (Y579) antibodies?

Phospho-PTK2B (Y579) antibodies are versatile tools suitable for multiple research applications:

These applications allow researchers to investigate PTK2B activation in various experimental contexts including cell culture, tissue samples, and protein extracts . When performing Western blot analysis, phosphorylated PYK2 often appears as a doublet with a molecular weight of approximately 116 kDa, representing electrophoretic mobility shifts resulting from phosphorylation at multiple sites .

How specific are Phospho-PTK2B (Y579) antibodies, and what controls should be included?

Most commercial Phospho-PTK2B (Y579) antibodies demonstrate high specificity for PTK2B phosphorylated at Y579. For example, the antibody described in search result "detects endogenous levels of PYK2 protein only when phosphorylated at Y579" and was generated using a synthesized peptide derived from human PYK2 around the phosphorylation site of Tyr579 within amino acid range 545-594 .

Recommended controls include:

• Positive control: Lysates from cells treated with stimuli known to activate PTK2B (e.g., calcium ionophores, angiotensin II, or thapsigargin)

• Negative control: Lysates from cells treated with SRC family kinase inhibitors, as Src mediates Y579 phosphorylation

• Validation control: PTK2B knockout or knockdown samples to confirm antibody specificity

• Peptide competition assay: Pre-incubation of the antibody with the immunizing phosphopeptide should abolish signal

These controls are essential for confirming the phospho-specificity of the antibody and validating experimental results .

How does the phosphorylation sequence at Y402 and Y579/Y580 coordinate PTK2B activation?

The phosphorylation of PTK2B follows a specific sequential pattern that integrates multiple signals:

• Initial autophosphorylation at Y402 occurs in response to stimuli that elevate intracellular calcium concentration, often mediated by reactive oxygen species (ROS)

• This autophosphorylation happens in trans, where one subunit of dimeric PTK2B phosphorylates tyrosine residues on the other subunit

• Phosphorylated Y402 creates a docking site for SRC and SRC family kinases through their SH2 domains

• Once bound, SRC phosphorylates PTK2B at Y579/Y580 in the activation loop

• Y579/Y580 phosphorylation increases PTK2B kinase activity substantially, enabling phosphorylation of downstream substrates

Recent research using molecularly imprinted nanoparticles (MINPs) has revealed that the Y402 site is conformationally constrained in the autoinhibited state due to the formation of a short beta-sheet with the FERM domain, similar to how FAK is regulated. Disruption of this regulatory structure results in autophosphorylation, allowing for the subsequent Src-mediated phosphorylation of Y579/Y580 .

What are the methodological considerations for detecting PTK2B Y579 phosphorylation in immunohistochemistry applications?

When performing immunohistochemistry with Phospho-PTK2B (Y579) antibodies, several technical considerations should be addressed:

• Fixation method: Phospho-epitopes are sensitive to fixation conditions. 4% paraformaldehyde fixation for 10-15 minutes is often optimal for preserving phosphorylation states

• Antigen retrieval: Heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 8.0) is recommended to unmask phospho-epitopes that may be cross-linked during fixation

• Signal amplification: For tissues with low expression levels, signal amplification methods such as tyramide signal amplification may be necessary

• Blocking conditions: Use 5-10% normal serum from the species of the secondary antibody with 0.1-0.3% Triton X-100 in PBS for 1-2 hours at room temperature to reduce background

• Primary antibody incubation: Overnight incubation at 4°C at dilutions between 1:100-1:300 is typically optimal for phospho-specific antibodies

• Counterstaining: PTK2B shows complex cellular localization patterns, including cytoplasm, perinuclear region, cell membrane, focal adhesions, and nucleus. Therefore, co-staining with cellular compartment markers is recommended for accurate interpretation

These methodological considerations help ensure specific and sensitive detection of phosphorylated PTK2B in tissue samples while minimizing background and false-positive results.

How can PTK2B Y579 phosphorylation be used as a biomarker in neurological research?

PTK2B Y579 phosphorylation has emerging value as a biomarker in neurological research, particularly in Alzheimer's disease studies:

• The PTK2B gene (encoding PYK2) is a confirmed Alzheimer's disease (AD) susceptibility variant, with the risk allele associated with increased mRNA levels, suggesting elevated Pyk2 protein expression

• Researchers have demonstrated that Pyk2 colocalizes with and phosphorylates tau, a key protein in AD pathology, indicating a potential role for PTK2B in tau hyperphosphorylation

• Monitoring Y579 phosphorylation can provide insights into PTK2B activation status in neuronal tissues and its relationship to tau phosphorylation states

• Experimental models have shown that Pyk2 functions downstream of Fyn, another established tau kinase, forming a kinase cascade relevant to tauopathy

When using Phospho-PTK2B (Y579) antibodies for neurological research, it's important to note that PTK2B exhibits particularly high expression levels in the brain, with highest concentrations in the amygdala and hippocampus - regions critically affected in Alzheimer's disease . Therefore, these antibodies can serve as valuable tools for investigating PTK2B's role in neurodegeneration and potential therapeutic interventions targeting this pathway.

What stimuli can be used to induce PTK2B Y579 phosphorylation in experimental settings?

Several stimuli can effectively induce PTK2B Y579 phosphorylation for experimental studies:

The search results indicate that in monocytes, adherence to substrata is required for tyrosine phosphorylation and kinase activation . In the context of viral infection, PTK2B appears to be activated as part of antiviral signaling pathways . Interestingly, during mouse oocyte fertilization, PTK2B shows increased phosphorylation during anaphase of the second meiotic division (45-75 minutes post insemination), with activity declining during the pronuclear and 2-cell stages .

How should researchers troubleshoot weak or non-specific signals when using Phospho-PTK2B (Y579) antibodies?

When encountering issues with Phospho-PTK2B (Y579) antibody applications, consider these troubleshooting approaches:

• Weak signal problems:

  • Ensure optimal sample preparation with phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) to preserve phosphorylation status

  • Optimize protein loading (25-50μg for WB applications)

  • Increase antibody concentration within the recommended range (1:500-1:1000 for WB)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use enhanced detection systems for low-abundance signals

• Non-specific signal issues:

  • Increase blocking time and concentration (5% BSA in TBST for 1-2 hours)

  • Test different dilutions of the antibody

  • Include positive and negative controls to distinguish specific from non-specific bands

  • Perform peptide competition assay with the immunizing phosphopeptide

  • Consider using PTK2B knockout or knockdown samples as specificity controls

• High background in IF/IHC:

  • Optimize blocking conditions (use 5-10% normal serum with 0.1-0.3% Triton X-100)

  • Reduce primary antibody concentration

  • Include additional washing steps with 0.1% Tween-20

  • Prepare absorption controls by pre-incubating the antibody with the immunizing phosphopeptide

Remember that tyrosine phosphorylated PYK2 typically appears as a doublet due to electrophoretic mobility shifts from phosphorylation at multiple sites, which is a normal pattern and not necessarily indicating non-specificity .

How can phospho-PTK2B (Y579) antibodies be used in combination with other tools to study PTK2B activation cascades?

Comprehensive analysis of PTK2B activation cascades benefits from combining phospho-PTK2B (Y579) antibodies with other research tools:

• Multi-phosphorylation site analysis:

  • Parallel detection with antibodies against different phosphorylation sites (pY402, pY579/580, pY881) to map the sequence of PTK2B activation

  • This approach can reveal the temporal dynamics of phosphorylation at different sites and their interdependence

• Kinase-substrate relationship studies:

  • Combine with Src family kinase activity assays, as Src mediates Y579 phosphorylation

  • Use selective inhibitors for upstream kinases to establish the signaling hierarchy

  • Perform in vitro kinase assays with recombinant proteins to confirm direct phosphorylation events

• Pathway integration analysis:

  • Pair with antibodies against downstream effectors (MAPK, PI3K, AKT) to link PTK2B activation to specific signaling outcomes

  • Use phospho-antibodies against potential PTK2B substrates (ASAP1, NPHP1, KCNA2, SHC1) to verify kinase activity

• Advanced molecular techniques:

  • Implement molecularly imprinted nanoparticles (MINPs) as conformational probes to investigate specific PTK2B structural states

  • Combine with proximity ligation assays to detect protein-protein interactions in situ

  • Use FRET-based biosensors to monitor PTK2B activation in live cells

• Genetic manipulation approaches:

  • Analyze PTK2B phosphorylation in knockout/knockdown models to identify compensatory mechanisms

  • Utilize site-directed mutagenesis (Y579F) to examine the specific contribution of this phosphorylation site

Recent research has employed such combinatorial approaches to reveal that PTK2B plays a crucial role in antiviral immunity by promoting TBK1 and STING oligomerization, with Ptk2b-knockout mice showing increased susceptibility to viral infections .

What is the role of PTK2B Y579 phosphorylation in immune cell function and antiviral responses?

PTK2B Y579 phosphorylation plays a significant role in immune cell regulation and antiviral immunity:

• Macrophage function:

  • PTK2B is required for normal macrophage polarization and migration toward sites of inflammation

  • Y579 phosphorylation contributes to cytoskeletal reorganization necessary for macrophage motility

• T-cell responses:

  • In T-cells, PTK2B regulates cytoskeleton rearrangement and cell spreading

  • Y579 phosphorylation contributes to T-cell receptor signaling pathways

• B-cell immunity:

  • PTK2B is required for normal levels of marginal B-cells in the spleen and proper migration of splenic B-cells

  • The phosphorylation state affects humoral immune response regulation

• Antiviral signaling:

  • Recent research demonstrates that PTK2B promotes TBK1 and STING oligomerization, enhancing antiviral responses

  • PTK2B directly phosphorylates TBK1 at residue Y591, augmenting its oligomer formation and activation

  • PTK2B also promotes STING oligomerization in a kinase-independent manner

  • Ptk2b-knockout mice show increased susceptibility to lethal herpes simplex virus type 1 (HSV-1) and vesicular stomatitis virus (VSV) infection

  • PTK2B knockdown reduces the levels of phosphorylated STING, TBK1, and IRF3 induced by viral infection

  • Ptk2b deficiency dramatically reduces mRNA levels of antiviral genes like Ifnb1, Ifit1, and Cxcl10 stimulated by viral infection

These findings highlight that monitoring PTK2B Y579 phosphorylation can provide valuable insights into immune cell activation states and antiviral defense mechanisms, making Phospho-PTK2B (Y579) antibodies important tools for immunological research.

How does PTK2B Y579 phosphorylation contribute to reproductive biology research?

PTK2B Y579 phosphorylation has specialized functions in reproductive biology that researchers should consider:

• Oocyte fertilization:

  • Studies have demonstrated that PTK2B functions during the sperm-egg fusion process or during the physical incorporation of sperm into the egg cytoplasm

  • Fertilization leads to a significant increase in total oocyte PYK2 PY579 content relative to GAPDH content, with activity declining during the pronuclear and 2-cell stages

  • This pattern differs from other kinases like FAK and SRC-family kinases, which do not show significant changes after fertilization

• Experimental detection considerations:

  • When studying fertilization events, researchers have observed that tyrosine phosphorylated PYK2 appears as a doublet, representing electrophoretic mobility shifts resulting from phosphorylation at multiple sites

  • For fertilization studies, samples are typically collected during specific developmental stages: anaphase of the second meiotic division (45-75 minutes post-insemination), pronuclear stage (5-8 hours post-insemination), and 2-cell stage (24-28 hours post-insemination)

• Experimental approaches:

  • Groups of 10-20 zona-free oocytes are typically fertilized under sperm-limiting conditions to produce relatively synchronous populations of monospermic fertilization events

  • Western blot with anti-PYK2 PY579 antibodies can be used to monitor temporal changes in PTK2B activation during fertilization and early embryonic development

  • Controls using specific kinase inhibitors can help elucidate the role of PTK2B phosphorylation in fertilization events

These findings indicate that Phospho-PTK2B (Y579) antibodies can serve as valuable tools for investigating signaling events during fertilization and early embryonic development.

What is the significance of PTK2B Y579 phosphorylation in neurological disorders research?

PTK2B Y579 phosphorylation has emerging importance in neurological disorders research, particularly Alzheimer's disease:

• Genetic associations:

  • The PTK2B gene is a confirmed Alzheimer's disease (AD) susceptibility variant

  • The PTK2B risk allele is associated with increased mRNA levels, suggesting elevated Pyk2 protein expression in individuals with this genetic variant

• Tau pathology connections:

  • Research has demonstrated that Pyk2 colocalizes, interacts with, and phosphorylates tau in vivo and in vitro

  • Pyk2/tau double-transgenic mice exhibit increased tyrosine phosphorylation and accumulation of tau

  • Monitoring Y579 phosphorylation can provide insights into PTK2B activation status and its relationship to tau pathology

• Kinase signaling network:

  • PTK2B interacts with the established tyrosine-directed tau kinase Fyn

  • Studies have identified increased Pyk2 activity in mice which constitutively overexpress Fyn (FynCA), and decreased activity in mice lacking Fyn (FynKO)

  • This positions PTK2B as a direct tyrosine kinase of tau that is active downstream of Fyn

• Experimental approaches:

  • Transgenic mouse models with neuronal expression of human Pyk2 can be used to study PTK2B's role in neurodegeneration

  • Phospho-PTK2B (Y579) antibodies enable monitoring of PTK2B activation status in brain tissue samples

  • Combined analysis of PTK2B Y402 and Y579 phosphorylation can provide insights into the sequential activation of PTK2B in neuronal tissues

These findings suggest that Phospho-PTK2B (Y579) antibodies represent valuable tools for investigating the role of PTK2B in neurodegenerative disorders, potentially contributing to the development of novel therapeutic strategies targeting this pathway.